SVAR LIFE SCIENCE AB has a total of 17 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Republic of Korea and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and measurement are GUANGZHOU TEBSUN BIO TECH DEV CO LTD, CADUS TECHNOLOGIES INC and AUGMENTA BIOWORKS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Republic of Korea | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Tovey Michael | 13 |
#2 | Lallemand Christophe | 13 |
#3 | Sommarin Yngve | 4 |
#4 | Witt Lisbeth | 4 |
#5 | Huang Lue | 2 |
#6 | Carlsén Stefan | 2 |
#7 | Hang Lue | 2 |
#8 | Vallett Benoit | 2 |
#9 | Carlsen Stefan | 1 |
#10 | Pramhed Anna | 1 |
Publication | Filing date | Title |
---|---|---|
EP3788060A1 | Complement c4d assay | |
WO2019197313A1 | Glucagon Assay | |
WO2019179871A1 | SYSTEM AND PRODUCTS FOR IMPROVED QUANTIFICATION OF ADCC and ADCP ACTIVITY | |
KR20190053965A | FGF21 reactive reporter gene cell line | |
US2019310251A1 | System and products for improved quantification of adcc activity |